126 related articles for article (PubMed ID: 38378000)
21. TGF-β activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastoma.
Wirsik NM; Ehlers J; Mäder L; Ilina EI; Blank AE; Grote A; Feuerhake F; Baumgarten P; Devraj K; Harter PN; Mittelbronn M; Naumann U
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):768-780. PubMed ID: 33780024
[TBL] [Abstract][Full Text] [Related]
22. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.
Ge Y; Weygant N; Qu D; May R; Berry WL; Yao J; Chandrakesan P; Zheng W; Zhao L; Zhao KL; Drake M; Vega KJ; Bronze MS; Tomasek JJ; An G; Houchen CW
Int J Cancer; 2018 Sep; 143(5):1162-1175. PubMed ID: 29577277
[TBL] [Abstract][Full Text] [Related]
23. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
[TBL] [Abstract][Full Text] [Related]
24. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
25. Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-β signaling.
Nikolakopoulou AM; Zhao Z; Montagne A; Zlokovic BV
PLoS One; 2017; 12(4):e0176225. PubMed ID: 28441414
[TBL] [Abstract][Full Text] [Related]
26. Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study.
Hammers HJ; Verheul HM; Salumbides B; Sharma R; Rudek M; Jaspers J; Shah P; Ellis L; Shen L; Paesante S; Dykema K; Furge K; Teh BT; Netto G; Pili R
Mol Cancer Ther; 2010 Jun; 9(6):1525-35. PubMed ID: 20501804
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-520f suppresses growth of gastric carcinoma cells by target ATPase family AAA domain-containing protein 2 (ATAD2).
Hong S; Bi M; Chen S; Zhao P; Li B; Sun D; Tai J
Neoplasma; 2016; 63(6):873-879. PubMed ID: 27565325
[TBL] [Abstract][Full Text] [Related]
28. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy.
Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Deng L; Lu Y
Biomed Pharmacother; 2018 Mar; 99():615-621. PubMed ID: 29653486
[TBL] [Abstract][Full Text] [Related]
29. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs.
Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500
[TBL] [Abstract][Full Text] [Related]
30. Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells.
Zhong Y; Guan K; Guo S; Zhou C; Wang D; Ma W; Zhang Y; Li C; Zhang S
Cancer Lett; 2010 Dec; 299(2):150-60. PubMed ID: 20846785
[TBL] [Abstract][Full Text] [Related]
31. ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target.
Fu J; Zhang J; Chen X; Liu Z; Yang X; He Z; Hao Y; Liu B; Yao D
Theranostics; 2023; 13(2):787-809. PubMed ID: 36632213
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab.
Lyu C; Stadlbauer B; Wang L; Buchner A; Pohla H
Front Immunol; 2023; 14():1186388. PubMed ID: 37622107
[TBL] [Abstract][Full Text] [Related]
33. Ecto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.
Song L; Ye W; Cui Y; Lu J; Zhang Y; Ding N; Hu W; Pei H; Yue Z; Zhou G
Oncotarget; 2017 May; 8(19):31977-31992. PubMed ID: 28404888
[TBL] [Abstract][Full Text] [Related]
34. Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma.
Huang D; Ding Y; Li Y; Luo WM; Zhang ZF; Snider J; Vandenbeldt K; Qian CN; Teh BT
Cancer Res; 2010 Feb; 70(3):1053-62. PubMed ID: 20103629
[TBL] [Abstract][Full Text] [Related]
35. SDF-1α induces PDGF-B expression and the differentiation of bone marrow cells into pericytes.
Hamdan R; Zhou Z; Kleinerman ES
Mol Cancer Res; 2011 Nov; 9(11):1462-70. PubMed ID: 21911740
[TBL] [Abstract][Full Text] [Related]
36. Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation.
Cho H; Kozasa T; Bondjers C; Betsholtz C; Kehrl JH
FASEB J; 2003 Mar; 17(3):440-2. PubMed ID: 12514120
[TBL] [Abstract][Full Text] [Related]
37. Pericyte-fibroblast transition promotes tumor growth and metastasis.
Hosaka K; Yang Y; Seki T; Fischer C; Dubey O; Fredlund E; Hartman J; Religa P; Morikawa H; Ishii Y; Sasahara M; Larsson O; Cossu G; Cao R; Lim S; Cao Y
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5618-27. PubMed ID: 27608497
[TBL] [Abstract][Full Text] [Related]
38. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
[TBL] [Abstract][Full Text] [Related]
39. PDGFR-β restores blood-brain barrier functions in a mouse model of focal cerebral ischemia.
Shen J; Xu G; Zhu R; Yuan J; Ishii Y; Hamashima T; Matsushima T; Yamamoto S; Takatsuru Y; Nabekura J; Sasahara M
J Cereb Blood Flow Metab; 2019 Aug; 39(8):1501-1515. PubMed ID: 29629621
[TBL] [Abstract][Full Text] [Related]
40. Expression of Components of the Renin-Angiotensin System by Cancer Stem Cells in Renal Clear Cell Carcinoma.
Siljee S; Milne B; Brasch HD; Bockett N; Patel J; Davis PF; Kennedy-Smith A; Itinteang T; Tan ST
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33916968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]